Home
About
About Pyrotech
LEADERSHIP TEAM
Contact Us
SCIENCE
TECHNOLOGIES
Pipeline
News
Careers
EN
CN
EN
News
The first novel ALPK1 activator for tumor immunotherapy developed by Pyrotech Therapeutics has obtained IND clearance from the FDA
2023-11-24
Pyrotech Therapeutics Announces Completion of 700 Million RMB Series A Financing
2023-07-10
Dr. Feng Shao Receives the 2022 The William B. Coley Award
2022-09-28
Media Contacts
+8610 8193 8000
info@pyrotech.com
+8610 8193 8000
info@pyrotech.com
